{"id":"https://openalex.org/W2146778486","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2402","title":"Dual Inhibition of mTOR and Estrogen Receptor SignalingIn vitroInduces Cell Death in Models of Breast Cancer","display_name":"Dual Inhibition of mTOR and Estrogen Receptor SignalingIn vitroInduces Cell Death in Models of Breast Cancer","alternate_titles":[],"publication_year":2005,"publication_date":"2005-07-15","ids":{"openalex":"https://openalex.org/W2146778486","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2402","mag":"2146778486","pmid":"https://pubmed.ncbi.nlm.nih.gov/16033851"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-04-2402","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2402","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-2402","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2146778486"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010632648","display_name":"Anne Boulay","orcid":"https://orcid.org/0000-0001-5620-6209","observed_orcids":["https://orcid.org/0000-0001-5620-6209"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Boulay","raw_affiliation_strings":["1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014219197","display_name":"Jo\u00eblle Rudloff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joelle Rudloff","raw_affiliation_strings":["1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048287446","display_name":"Jingjing Ye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jingjing Ye","raw_affiliation_strings":["2City of Hope National Medical Center and Beckman Research Institute, Duarte, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2City of Hope National Medical Center and Beckman Research Institute, Duarte, California","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030178833","display_name":"Sabine Zumstein-Mecker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sabine Zumstein-Mecker","raw_affiliation_strings":["1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109451348","display_name":"Terence O\u2019Reilly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Terence O'Reilly","raw_affiliation_strings":["1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113962845","display_name":"Dean B. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dean B. Evans","raw_affiliation_strings":["1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064649529","display_name":"Shiuan Chen","orcid":"https://orcid.org/0000-0002-4482-6926","observed_orcids":["https://orcid.org/0000-0002-4482-6926"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shiuan Chen","raw_affiliation_strings":["2City of Hope National Medical Center and Beckman Research Institute, Duarte, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2City of Hope National Medical Center and Beckman Research Institute, Duarte, California","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082438939","display_name":"Heidi A. Lane","orcid":"https://orcid.org/0000-0003-2432-0212","observed_orcids":["https://orcid.org/0000-0003-2432-0212"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heidi A. Lane","raw_affiliation_strings":["1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Novartis Institutes for BioMedical Research Basel, Oncology Research, Novartis Pharma AG, Basel, Switzerland and","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.5717,"has_fulltext":false,"cited_by_count":365,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97544346,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"11","issue":"14","first_page":"5319","last_page":"5328"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.038100000470876694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.878000020980835},{"id":"https://openalex.org/keywords/estrogen-receptor-signaling","display_name":"estrogen receptor signaling","score":0.8659999966621399},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.7870000004768372},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.8360000252723694},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.8100000023841858},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6990000009536743},{"id":"https://openalex.org/keywords/androstenedione","display_name":"androstenedione","score":0.8569999933242798},{"id":"https://openalex.org/keywords/estradiol","display_name":"estradiol","score":0.8069999814033508},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6079999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5720000267028809},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.7390000224113464},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.7680000066757202},{"id":"https://openalex.org/keywords/t47d-cells","display_name":"T47D cells","score":0.953000009059906},{"id":"https://openalex.org/keywords/hormone-dependent-breast-cancer","display_name":"hormone-dependent breast cancer","score":0.9179999828338623}],"concepts":[{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.8560542464256287},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7546262145042419},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.7498509287834167},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.6706417798995972},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.6504815816879272},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.583316445350647},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5507841110229492},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.4869152307510376},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.44250237941741943},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.43525606393814087},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4190579056739807},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41333770751953125},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.40401893854141235},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37098532915115356},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3631505072116852},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3524707853794098},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04500505328178406}],"mesh":[{"descriptor_ui":"D000068338","descriptor_name":"Everolimus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077289","descriptor_name":"Letrozole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004967","descriptor_name":"Estrogens","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-04-2402","doi":"https://doi.org/10.1158/1078-0432.ccr-04-2402","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-04-2402","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16033851","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16033851","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.540.4342","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.540.4342","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.targeting-the-kinome.org/images/Lane.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W42013536","https://openalex.org/W206480088","https://openalex.org/W1555945582","https://openalex.org/W1671912264","https://openalex.org/W1821586326","https://openalex.org/W1827067753","https://openalex.org/W1918073772","https://openalex.org/W1934173384","https://openalex.org/W1975960976","https://openalex.org/W1978282886","https://openalex.org/W1987058957","https://openalex.org/W1991925666","https://openalex.org/W2005173284","https://openalex.org/W2010296464","https://openalex.org/W2011705265","https://openalex.org/W2016569614","https://openalex.org/W2017018900","https://openalex.org/W2021254773","https://openalex.org/W2026569756","https://openalex.org/W2029882446","https://openalex.org/W2037600362","https://openalex.org/W2041699254","https://openalex.org/W2072583138","https://openalex.org/W2076189206","https://openalex.org/W2080457496","https://openalex.org/W2085856374","https://openalex.org/W2089896609","https://openalex.org/W2091890568","https://openalex.org/W2093465294","https://openalex.org/W2093666377","https://openalex.org/W2100506877","https://openalex.org/W2101881391","https://openalex.org/W2102648794","https://openalex.org/W2104919541","https://openalex.org/W2105516763","https://openalex.org/W2106181427","https://openalex.org/W2113011586","https://openalex.org/W2121117803","https://openalex.org/W2121155074","https://openalex.org/W2123664371","https://openalex.org/W2127720974","https://openalex.org/W2133764838","https://openalex.org/W2142364508","https://openalex.org/W2142506125","https://openalex.org/W2164895949","https://openalex.org/W2169988894","https://openalex.org/W2171423946","https://openalex.org/W2388163742"],"related_works":["https://openalex.org/W2037403469","https://openalex.org/W1986763334","https://openalex.org/W2252337940","https://openalex.org/W2143439281","https://openalex.org/W2105529705","https://openalex.org/W2076656264","https://openalex.org/W856819346","https://openalex.org/W2610242496","https://openalex.org/W2404398960"],"abstract_inverted_index":{"PURPOSE:":[0],"RAD001":[1,67,102],"(everolimus),":[2],"a":[3,145,192,238],"mammalian":[4],"target":[5],"of":[6,47,56,65,83,101,114,132,141,180,256],"rapamycin":[7],"(mTOR)":[8],"pathway":[9,59,86],"inhibitor":[10,43],"in":[11,16,60,72,74,87,92,107,163,195,237],"phase":[12],"II":[13],"clinical":[14],"trials":[15],"oncology,":[17],"exerts":[18],"potent":[19],"antiproliferative/antitumor":[20],"activities.":[21],"Many":[22],"breast":[23,52,76,95,228,258],"cancers":[24],"are":[25],"dependent":[26],"for":[27,45,226,253],"proliferation":[28,62,111,122,243],"on":[29,109,188],"estrogens":[30],"synthesized":[31],"from":[32],"androgens":[33],"(i.e.,":[34],"androstenedione)":[35],"by":[36,98,148,175],"aromatase.":[37],"Letrozole":[38],"(Femara)":[39],"is":[40,224],"an":[41],"aromatase":[42],"used":[44],"treatment":[46,255],"postmenopausal":[48],"women":[49],"with":[50,135,184,217],"hormone-dependent":[51,257],"cancers.":[53,259],"The":[54,81],"role":[55,82],"the":[57,84,110,142,181,254],"mTOR":[58,85,143,222],"estrogen-driven":[61],"and":[63,68,103,106,112,116,127,154,191,244],"effects":[64,187],"combining":[66],"letrozole":[69,104,149],"were":[70,119],"examined":[71],"vitro":[73],"two":[75],"cancer":[77,96],"models.":[78],"EXPERIMENTAL":[79],"DESIGN:":[80],"estrogen":[88],"response":[89],"was":[90,166,214],"evaluated":[91,120],"aromatase-expressing":[93],"MCF7/Aro":[94,115,133,153],"cells":[97,118,134],"immunoblotting.":[99],"Effects":[100],"(alone":[105],"combination)":[108],"survival":[113],"T47D/Aro":[117,155],"using":[121],"assays,":[123],"flow":[124],"cytometry,":[125],"immunoblotting,":[126],"apoptosis":[128,205],"analyses.":[129],"RESULTS:":[130],"Treatment":[131],"estradiol":[136],"or":[137,150],"androstenedione":[138],"caused":[139],"modulation":[140],"pathway,":[144],"phenomenon":[146],"reversed":[147],"RAD001.":[151],"In":[152],"cells,":[156],"both":[157],"agents":[158],"inhibited":[159],"androstenedione-induced":[160],"proliferation;":[161],"however,":[162],"combination,":[164],"this":[165],"significantly":[167],"augmented":[168],"(P":[169,198,206],"<":[170,199,207],"0.001,":[171],"two-way":[172,201],"ANOVA,":[173],"synergy":[174],"isobologram":[176],"analysis).":[177],"Increased":[178,211],"activity":[179],"combination":[182,250],"correlated":[183],"more":[185],"profound":[186],"G1":[189],"progression":[190],"significant":[193],"decrease":[194],"cell":[196,212,230,247],"viability":[197],"0.01,":[200],"ANOVA)":[202],"defined":[203],"as":[204],"0.05,":[208],"Friedman":[209],"test).":[210],"death":[213],"particularly":[215],"evident":[216],"optimal":[218],"drug":[219],"concentrations.":[220],"CONCLUSION:":[221],"signaling":[223],"required":[225],"estrogen-induced":[227],"tumor":[229],"proliferation.":[231],"Moreover,":[232],"RAD001-letrozole":[233],"combinations":[234],"can":[235],"act":[236],"synergistic":[239],"manner":[240],"to":[241],"inhibit":[242],"trigger":[245],"apoptotic":[246],"death.":[248],"This":[249],"holds":[251],"promise":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2146778486","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":24},{"year":2016,"cited_by_count":27},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":48},{"year":2012,"cited_by_count":25}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
